{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:12:01Z","timestamp":1792023121176,"version":"4.4.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s40744-025-00759-5","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T19:46:32Z","timestamp":1743191192000},"page":"407-419","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Psychological Health in the Management of Patients with Psoriatic Arthritis: An Intricate Relationship"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6189-5328","authenticated-orcid":false,"given":"Ennio","family":"Lubrano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9398-0428","authenticated-orcid":false,"given":"Pasquale","family":"Ambrosino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3771-5205","authenticated-orcid":false,"given":"Fabio Massimo","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"issue":"Suppl II","key":"759_CR1","doi-asserted-by":"publisher","first-page":"ii14","DOI":"10.1136\/ard.2004.032482","volume":"64","author":"DD Gladman","year":"2005","unstructured":"Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64(Suppl II):ii14\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"759_CR2","first-page":"1438","volume":"35","author":"LC Coates","year":"2008","unstructured":"Coates LC, Anderson RR, Fitzgerald O, et al. Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review. J Rheumatol. 2008;35(7):1438\u201342.","journal-title":"J Rheumatol"},{"issue":"11","key":"759_CR3","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.3899\/jrheum.190054","volume":"46","author":"E Lubrano","year":"2019","unstructured":"Lubrano E, Scriffignano S, Perrotta FM. Psoriatic arthritis, psoriatic disease, or psoriatic syndrome? J Rheumatol. 2019;46(11):1428\u201330.","journal-title":"J Rheumatol"},{"issue":"8","key":"759_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41584-022-00798-0","volume":"18","author":"LC Coates","year":"2022","unstructured":"Coates LC, Soriano ER, Corp N, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nat Rev Rheumatol. 2022;18(8):465\u201379. https:\/\/doi.org\/10.1038\/s41584-022-00798-0.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"759_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003339","volume":"9","author":"E Lubrano","year":"2023","unstructured":"Lubrano E, Scriffignano S, de Vlam K, Ronga M, Perrotta FM, Lories R. Triple jump for the optimal management of psoriatic arthritis: diet, sleep and exercise\u2014a review. RMD Open. 2023;9(3):e003339. https:\/\/doi.org\/10.1136\/rmdopen-2023-003339.","journal-title":"RMD Open"},{"issue":"2","key":"759_CR6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s40744-021-00298-9","volume":"8","author":"FM Perrotta","year":"2021","unstructured":"Perrotta FM, Scriffignano S, Benfaremo D, Ronga M, Luchetti MM, Lubrano E. New insights in physical therapy and rehabilitation in psoriatic arthritis: a review. Rheumatol Ther. 2021;8(2):639\u201349.","journal-title":"Rheumatol Ther"},{"issue":"5","key":"759_CR7","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s40744-023-00574-w","volume":"10","author":"E Lubrano","year":"2023","unstructured":"Lubrano E, Scriffignano S, Perrotta FM. Difficult to treat and refractory to treatment in psoriatic arthritis. Rheumatol Ther. 2023;10(5):1119\u201325.","journal-title":"Rheumatol Ther"},{"issue":"5","key":"759_CR8","first-page":"1015","volume":"42","author":"R Bixio","year":"2024","unstructured":"Bixio R, Bonetto C, Fracassi E, et al. Depression as a possible determinant of fatigue in patients with axial spondyloarthritis. Clin Exp Rheumatol. 2024;42(5):1015\u20139.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"759_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.semarthrit.2017.05.010","volume":"47","author":"ME Husni","year":"2017","unstructured":"Husni ME, Merola JF, Davin S. The psychosocial burden of psoriatic arthritis. Semin Arthritis Rheum. 2017;47(3):351\u201360. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.05.010.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"759_CR10","doi-asserted-by":"publisher","first-page":"597","DOI":"10.5114\/ada.2020.93242","volume":"37","author":"B Jankowiak","year":"2020","unstructured":"Jankowiak B, Kowalewska B, Krajewska-Ku\u0142ak E, Khvorik DF, Niczyporuk W. Relationship between self-esteem and stigmatization in psoriasis patients. Postepy Dermatol Alergol. 2020;37(4):597\u2013602. https:\/\/doi.org\/10.5114\/ada.2020.93242.","journal-title":"Postepy Dermatol Alergol"},{"issue":"4","key":"759_CR11","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s40744-020-00229-0","volume":"7","author":"E Lubrano","year":"2020","unstructured":"Lubrano E, Scriffignano S, Azuaga AB, Ramirez J, Ca\u00f1ete JD, Perrotta FM. Impact of comorbidities on disease activity, patient global assessment, and function in psoriatic arthritis: a cross-sectional study. Rheumatol Ther. 2020;7(4):825\u201336. https:\/\/doi.org\/10.1007\/s40744-020-00229-0.","journal-title":"Rheumatol Ther"},{"issue":"3","key":"759_CR12","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3390\/healthcare10030426","volume":"10","author":"M B\u0105k-Sosnowska","year":"2022","unstructured":"B\u0105k-Sosnowska M, Gruszczy\u0144ska M, Wyszomirska J, Daniel-Siela\u0144czyk A. The influence of selected psychological factors on medication adherence in patients with chronic diseases. Healthcare (Basel). 2022;10(3):426. https:\/\/doi.org\/10.3390\/healthcare10030426.","journal-title":"Healthcare (Basel)"},{"issue":"1","key":"759_CR13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13075-024-03396-5","volume":"26","author":"D Currado","year":"2024","unstructured":"Currado D, Saracino F, Ruscitti P, et al. Pain catastrophizing negatively impacts drug retention rate in patients with psoriatic arthritis and axial spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study. Arthritis Res Ther. 2024;26(1):162.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"759_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s40744-019-00170-x","volume":"6","author":"FM Perrotta","year":"2019","unstructured":"Perrotta FM, Musto A, Lubrano E. New insights in physical therapy and rehabilitation in axial spondyloarthritis: a review. Rheumatol Ther. 2019;6(4):479\u201386.","journal-title":"Rheumatol Ther"},{"issue":"10","key":"759_CR15","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1007\/s13555-022-00802-1","volume":"12","author":"E Bartholomew","year":"2022","unstructured":"Bartholomew E, Chung M, Yeroushalmi S, Hakimi M, Bhutani T, Liao W. Mindfulness and meditation for psoriasis: a systematic review. Dermatol Ther (Heidelb). 2022;12(10):2273\u201383. https:\/\/doi.org\/10.1007\/s13555-022-00802-1.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"Suppl 1","key":"759_CR16","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1002\/msc.1690","volume":"20","author":"DR Jadon","year":"2022","unstructured":"Jadon DR, Helliwell PS. The role of the multidisciplinary team in the management of psoriatic arthritis. Musculoskelet Care. 2022;20(Suppl 1):S32\u201340. https:\/\/doi.org\/10.1002\/msc.1690.","journal-title":"Musculoskelet Care"},{"issue":"11","key":"759_CR17","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD. Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int. 2011;31(11):1409\u201317. https:\/\/doi.org\/10.1007\/s00296-011-1999-3.","journal-title":"Rheumatol Int"},{"issue":"1","key":"759_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10067-019-04734-8","volume":"39","author":"SS Zhao","year":"2020","unstructured":"Zhao SS, Miller N, Harrison N, Duffield SJ, Dey M, Goodson NJ. Systematic review of mental health comorbidities in psoriatic arthritis. Clin Rheumatol. 2020;39(1):217\u201325. https:\/\/doi.org\/10.1007\/s10067-019-04734-8.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"759_CR19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2340\/0001555576467471","volume":"76","author":"RJ Harvima","year":"1996","unstructured":"Harvima RJ, Viinam\u00e4ki H, Harvima IT, et al. Association of psychic stress with clinical severity and symptoms of psoriatic patients. Acta Derm Venereol. 1996;76(6):467\u201371.","journal-title":"Acta Derm Venereol"},{"issue":"Pt A","key":"759_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111046","volume":"125","author":"R Chaudhary","year":"2023","unstructured":"Chaudhary R, Prasad A, Agarwal V, et al. Chronic stress predisposes to the aggravation of inflammation in autoimmune diseases with focus on rheumatoid arthritis and psoriasis. Int Immunopharmacol. 2023;125(Pt A): 111046.","journal-title":"Int Immunopharmacol"},{"key":"759_CR21","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/j.1365-2133.2010.09984.x","volume":"163","author":"AW Evers","year":"2010","unstructured":"Evers AW, Verhoeven EW, Kraaimaat FW, et al. How stress gets under the skin: cortisol and stress reactivity in psoriasis. Br J Dermatol. 2010;163:986\u201391. https:\/\/doi.org\/10.1111\/j.1365-2133.2010.09984.x.","journal-title":"Br J Dermatol"},{"issue":"6","key":"759_CR22","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1111\/j.1365-2133.2005.06817.x","volume":"153","author":"HL Richards","year":"2005","unstructured":"Richards HL, Ray DW, Kirby B, et al. Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis. Br J Dermatol. 2005;153(6):1114\u201320. https:\/\/doi.org\/10.1111\/j.1365-2133.2005.06817.x.","journal-title":"Br J Dermatol"},{"key":"759_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/403908","author":"JM Hall","year":"2012","unstructured":"Hall JM, Cruser D, Podawiltz A, Mummert DI, Jones H, Mummert ME. Psychological stress and the cutaneous immune response: roles of the HPA axis and the sympathetic nervous system in atopic dermatitis and psoriasis. Dermatol Res Pract. 2012. https:\/\/doi.org\/10.1155\/2012\/403908.","journal-title":"Dermatol Res Pract"},{"issue":"9","key":"759_CR24","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.clinthera.2023.05.009","volume":"45","author":"LH Hailey","year":"2023","unstructured":"Hailey LH, Amarnani R, Bundy C, et al. Lifestyle modifications and nonpharmacologic interventions to improve outcomes in psoriatic arthritis: a systematic review. Clin Ther. 2023;45(9):841\u201351.","journal-title":"Clin Ther"},{"issue":"12","key":"759_CR25","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1136\/annrheumdis-2014-205389","volume":"74","author":"P H\u00f8jgaard","year":"2015","unstructured":"H\u00f8jgaard P, Glintborg B, Hetland ML, et al. Association between tobacco smoking and response to tumour necrosis factor \u03b1 inhibitor treatment in psoriatic arthritis: results from the DANBIO registry. Ann Rheum Dis. 2015;74(12):2130\u20136. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205389.","journal-title":"Ann Rheum Dis"},{"key":"759_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.reuma.2010.03.003","volume":"1","author":"M Freire","year":"2011","unstructured":"Freire M, Rodr\u00edguez J, M\u00f6ller I, et al. Prevalence of symptoms of anxiety and depression in patients with psoriatic arthritis attending rheumatology clinics. Reumatol Clin. 2011;1:20\u20136.","journal-title":"Reumatol Clin"},{"issue":"11","key":"759_CR27","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1136\/annrheumdis-2017-211284","volume":"76","author":"B Michelsen","year":"2017","unstructured":"Michelsen B, Kristianslund EK, Sexton J, et al. Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Ann Rheum Dis. 2017;76(11):1906\u201310.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"759_CR28","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/acr.24593","volume":"74","author":"A Wong","year":"2022","unstructured":"Wong A, Ye JY, Cook RJ, Gladman DD, Chandran V. Depression and anxiety reduce the probability of achieving a state of sustained minimal disease activity in patients with psoriatic arthritis. Arthritis Care Res (Hoboken). 2022;74(9):1430\u20134.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"759_CR29","doi-asserted-by":"publisher","first-page":"5734","DOI":"10.1093\/rheumatology\/keab242","volume":"60","author":"SS Zhao","year":"2021","unstructured":"Zhao SS, Jones GT, Hughes DM, et al. Depression and anxiety symptoms at TNF inhibitor initiation are associated with impaired treatment response in axial spondyloarthritis. Rheumatology. 2021;60(12):5734\u201342.","journal-title":"Rheumatology"},{"key":"759_CR30","doi-asserted-by":"publisher","unstructured":"Seiler A. Fagundes CP, Christian LM. The impact of everyday stressors on the immune system and health. In: Chouk\u00e8r A, editor. Stress challenges and immunity in space. Cham; Springer: 2020. https:\/\/doi.org\/10.1007\/978-3-030-16996-1_6.","DOI":"10.1007\/978-3-030-16996-1_6"},{"key":"759_CR31","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1007\/s10067-022-06300-1","volume":"41","author":"SA Tabra","year":"2022","unstructured":"Tabra SA, Elghany SEA, Amer RA, Fouda MH, Abu-Zaid MH. Serum interleukin-23 levels: relation to depression, anxiety, and disease activity in psoriatic arthritis patients. Clin Rheumatol. 2022;41:3391\u20139.","journal-title":"Clin Rheumatol"},{"key":"759_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24643","volume":"36","author":"N Tong","year":"2022","unstructured":"Tong N, Zhang Y, Yang A, Dai X, Hao S. The potency of common proinflammatory cytokines measurement for revealing the risk and severity of anxiety and depression in psoriasis patients. J Clin Lab Anal. 2022;36:e24643.","journal-title":"J Clin Lab Anal"},{"issue":"9","key":"759_CR33","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1111\/jdv.19192","volume":"37","author":"U Mrowietz","year":"2023","unstructured":"Mrowietz U, S\u00fcmb\u00fcl M, Gerdes S. Depression, a major comorbidity of psoriatic disease, is caused by metabolic inflammation. J Eur Acad Dermatol Venereol. 2023;37(9):1731\u20138. https:\/\/doi.org\/10.1111\/jdv.19192.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"759_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jaad.2017.08.024","volume":"78","author":"MG Lebwohl","year":"2018","unstructured":"Lebwohl MG, Papp KA, Marangell LB, et al. Psychiatric adverse events during treatment with brodalumab: analysis of psoriasis clinical trials. J Am Acad Dermatol. 2018;78(1):81\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"759_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1136\/annrheumdis-2019-216835","volume":"80","author":"PJ Mease","year":"2021","unstructured":"Mease PJ, Helliwell PS, Hjuler KF, Raymond K, McInnes I. Brodalumab in psoriatic arthritis: results from the randomised phase\u00a0III AMVISION-1 and AMVISION-2 trials. Ann Rheum Dis. 2021;80:185\u201393.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"759_CR36","first-page":"859","volume":"23","author":"DT Rubin","year":"2017","unstructured":"Rubin DT, Mittal M, Davis M, Johnson S, Chao J, Skup M. Impact of a patient support program on patient adherence to adalimumab and direct medical costs in Crohn\u2019s disease, ulcerative colitis, rheumatoid arthritis, psoriasis, psoriatic arthritis, and ankylosing spondylitis. J Manag Care Spec Pharm. 2017;23(8):859\u201367.","journal-title":"J Manag Care Spec Pharm"},{"issue":"10","key":"759_CR37","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1136\/annrheumdis-2021-220249","volume":"80","author":"E Nikiphorou","year":"2021","unstructured":"Nikiphorou E, Santos EJF, Marques A, et al. 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis. Ann Rheum Dis. 2021;80(10):1278\u201385. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220249.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"759_CR38","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s40744-023-00602-9","volume":"10","author":"N Frede","year":"2023","unstructured":"Frede N, Hiestand S, Schauer F, et al. Psoriasis and psoriatic arthritis have a major impact on quality of life and depressive symptoms: a cross-sectional study of 300 patients. Rheumatol Ther. 2023;10(6):1655\u201368. https:\/\/doi.org\/10.1007\/s40744-023-00602-9.","journal-title":"Rheumatol Ther"},{"issue":"1","key":"759_CR39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.55563\/clinexprheumatol\/8qxo80","volume":"41","author":"CG Gialouri","year":"2023","unstructured":"Gialouri CG, Evangelatos G, Zhao SS, et al. Depression and anxiety in a real-world psoriatic arthritis longitudinal study: should we focus more on patients\u2019 perception? Clin Exp Rheumatol. 2023;41(1):159\u201365. https:\/\/doi.org\/10.55563\/clinexprheumatol\/8qxo80.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"759_CR40","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/RHU.0000000000001077","volume":"26","author":"Y Wohl","year":"2020","unstructured":"Wohl Y, Reitblat O, Lerman TT, Cohen O, Reitblat T. Psychologic morbidity among psoriatic arthritis patients in remission or with low disease activity: a comparison between biologic and conventional synthetic disease-modifying antirheumatic drugs. J Clin Rheumatol. 2020;26(6):260.","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"759_CR41","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1348\/014466505X29657","volume":"44","author":"JD Henry","year":"2005","unstructured":"Henry JD, Crawford JR. The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br J Clin Psychol. 2005;44(2):227\u201339.","journal-title":"Br J Clin Psychol"},{"issue":"3","key":"759_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06473","volume":"7","author":"L Peters","year":"2021","unstructured":"Peters L, Peters A, Andreopoulos E, Pollock N, Pande RL, Mochari-Greenberger H. Comparison of DASS-21, PHQ-8, and GAD-7 in a virtual behavioral health care setting. Heliyon. 2021;7(3):e06473.","journal-title":"Heliyon"},{"key":"759_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpsy.2020.10.002","author":"P Miller","year":"2020","unstructured":"Miller P, Newby D, Walkom E, Schneider J, Li SC, Evans TJ. The performance and accuracy of depression screening tools capable of self-administration in primary care: a systematic review and meta-analysis. Eur J Psychiatry. 2020. https:\/\/doi.org\/10.1016\/j.ejpsy.2020.10.002.","journal-title":"Eur J Psychiatry"},{"issue":"6","key":"759_CR44","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/annrheumdis-2014-206807","volume":"74","author":"HA Zangi","year":"2015","unstructured":"Zangi HA, Ndosi M, Adams J, et al. EULAR recommendations for patient education for people with inflammatory arthritis. Ann Rheum Dis. 2015;74(6):954\u201362.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"759_CR45","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/BOR.0000000000000801","volume":"33","author":"AO Adebajo","year":"2021","unstructured":"Adebajo AO, Akintayo RO. Patient educational needs and challenges in psoriatic arthritis. Curr Opin Rheumatol. 2021;33(4):356\u201362.","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"759_CR46","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.3899\/jrheum.210010","volume":"48","author":"F Mahmood","year":"2021","unstructured":"Mahmood F, English B, Waxman R, et al. Development of an instrument for patient self-assessment in psoriatic arthritis. J Rheumatol. 2021;48(11):1680\u20135.","journal-title":"J Rheumatol"},{"issue":"3","key":"759_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003190","volume":"9","author":"L Hailey","year":"2023","unstructured":"Hailey L, Howells L, Bundy C, et al. Developing evidence-based patient-focused learning materials to support health behaviour change for people living with psoriatic arthritis. RMD Open. 2023;9(3):e003190. https:\/\/doi.org\/10.1136\/rmdopen-2023-003190.","journal-title":"RMD Open"},{"key":"759_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2023.152203","volume":"60","author":"AJ Damgaard","year":"2023","unstructured":"Damgaard AJ, Primdahl J, Esbensen BA, Latocha KM, Bremander A. Self-management support needs of patients with inflammatory arthritis and the content of self-management interventions: a scoping review. Semin Arthritis Rheum. 2023;60:152203. https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152203.","journal-title":"Semin Arthritis Rheum"},{"issue":"46","key":"759_CR49","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000027720","volume":"100","author":"C Tan","year":"2021","unstructured":"Tan C, Jiang J, Deng X, Xiang W, Hu T. Effect of cognitive behavioural therapy on anxiety and depression in patients with psoriasis: a protocol for systematic review and meta-analysis. Medicine (Baltimore). 2021;100(46):e27720.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"759_CR50","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10865-018-9984-x","volume":"42","author":"S Mehta","year":"2019","unstructured":"Mehta S, Peynenburg VA, Hadjistavropoulos HD. Internet-delivered cognitive behaviour therapy for chronic health conditions: a systematic review and meta-analysis. J Behav Med. 2019;42(2):169\u201387.","journal-title":"J Behav Med"},{"key":"759_CR51","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2147\/PRBM.S195181","volume":"12","author":"Y Xiao","year":"2019","unstructured":"Xiao Y, Zhang X, Luo D, et al. The efficacy of psychological interventions on psoriasis treatment: a systematic review and meta-analysis of randomized controlled trials. Psychol Res Behav Manag. 2019;12:97\u2013106.","journal-title":"Psychol Res Behav Manag"},{"issue":"3","key":"759_CR52","first-page":"349","volume":"18","author":"N Amani","year":"2020","unstructured":"Amani N, Haji alizadeh K, Zarei E, Dortaj F. Effectiveness of intensive short-term dynamic psychotherapy on anxiety in rheumatoid arthritis patients. Res Behav Sci. 2020;18(3):349\u201358.","journal-title":"Res Behav Sci"},{"key":"759_CR53","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1136\/annrheumdis-2024-eular.2333","volume":"83","author":"E Toledano","year":"2024","unstructured":"Toledano E, P\u00e9rez-Sancrist\u00f3bal I, Montilla C. AB0411 effect of a mindfulness-based intervention on the health and well-being of patients with psoriatic arthritis. Ann Rheum Dis. 2024;83:1455.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"759_CR54","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11926-020-00956-x","volume":"22","author":"JA Roberts 4th","year":"2020","unstructured":"Roberts JA 4th, Mandl LA. Complementary and alternative medicine use in psoriatic arthritis patients: a review. Curr Rheumatol Rep. 2020;22(11):81. https:\/\/doi.org\/10.1007\/s11926-020-00956-x.","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"759_CR55","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jcm.2019.12.005","volume":"19","author":"BR Martin","year":"2020","unstructured":"Martin BR. Treatment of psoriatic arthritis with acupuncture, turmeric (Curcuma longa), sarsaparilla (Smilax officinalis) and vitamin\u00a0D: a case report. J Chiropr Med. 2020;19(3):194\u2013200. https:\/\/doi.org\/10.1016\/j.jcm.2019.12.005.","journal-title":"J Chiropr Med"},{"issue":"30","key":"759_CR56","doi-asserted-by":"publisher","first-page":"5264977","DOI":"10.1155\/2022\/5264977)","volume":"2022","author":"H Li","year":"2022","unstructured":"Li H, Man S, Zhang L, Hu L, Song H. Clinical efficacy of acupuncture for the treatment of rheumatoid arthritis: meta-analysis of randomized clinical trials. Evid Based Complement Alternat Med. 2022;2022(30):5264977. https:\/\/doi.org\/10.1155\/2022\/5264977).","journal-title":"Evid Based Complement Alternat Med"},{"key":"759_CR57","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3390\/life13051219","volume":"13","author":"TL Timis","year":"2023","unstructured":"Timis TL, Beni L, Mocan T, Florian IA, Orasan RI. Biologic therapies decrease disease severity and improve depression and anxiety symptoms in psoriasis patients. Life. 2023;13:1219. https:\/\/doi.org\/10.3390\/life13051219.","journal-title":"Life"},{"issue":"4","key":"759_CR58","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1007\/s40744-021-00377-x","volume":"8","author":"V Strand","year":"2021","unstructured":"Strand V, Van den Bosch F, Ranza R, et al. Patient-reported outcomes in psoriatic arthritis patients with an inadequate response to biologic disease-modifying antirheumatic drugs: SELECT-PsA 2. Rheumatol Ther. 2021;8(4):1827\u201344.","journal-title":"Rheumatol Ther"},{"issue":"3","key":"759_CR59","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S2665-9913(21)00354-4","volume":"4","author":"V Strand","year":"2022","unstructured":"Strand V, Kaeley GS, Bergman MJ, et al. The effect of secukinumab on patient-reported outcomes in patients with active psoriatic arthritis in a randomised phase\u00a03 trial. Lancet Rheumatol. 2022;4(3):208\u201319.","journal-title":"Lancet Rheumatol"},{"issue":"10","key":"759_CR60","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1002\/acr.22044","volume":"65","author":"A Kavanaugh","year":"2013","unstructured":"Kavanaugh A, McInnes IB, Krueger GG, et al. Patient-reported outcomes and the association with clinical response in patients with active psoriatic arthritis treated with golimumab: findings through 2\u00a0years of a phase\u00a0III, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Care Res (Hoboken). 2013;65(10):1666\u201373.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"759_CR61","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s40744-024-00655-4","volume":"11","author":"FM Perrotta","year":"2024","unstructured":"Perrotta FM, Scrivo R, D\u2019Angelo S, et al. Assessment of patient-physician interactions in psoriatic arthritis: national results of the ASSIST study. Rheumatol Ther. 2024;11(3):553\u201362.","journal-title":"Rheumatol Ther"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-025-00759-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-025-00759-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-025-00759-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T12:43:16Z","timestamp":1747399396000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-025-00759-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["759"],"URL":"https:\/\/doi.org\/10.1007\/s40744-025-00759-5","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Pasquale Ambrosino has nothing to disclose. Ennio Lubrano and Fabio Massimo Perrotta are members of the Editorial Board of Rheumatology and Therapy. Ennio Lubrano and Fabio Massimo Perrotta were not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}